[apathy]

Publishing sometimes does 1), and rarely does 2) (as a statistician you surely know that the relationship between impact factor and retraction is nonlinear and rises in strength as you get into CNS, NEJM, and the like).

I review for others because others have done 1) for me. But I'll never review for Elsevier, and lately I've had the luxury of reviewing for the most cited of open journals (by operating bioRxiv, and accepting direct submissions from it, I claim that Genome Research is "close enough").

It makes me very happy that this is possible (my CV has not suffered for only publishing as first author, and whenever possible as senior or co-senior, in fully open journals). I'm pretty sure this wasn't possible for most people a few short years ago. That engenders optimism about the future of scholarship, for me at least.

Hopefully you as well.